Control of Metabolic and Cardiovascular Risk in Patients With Schizophrenia and Overweight (CRESSOB)

Viatris

Status: Completed

Conditions: Schizophrenia

Treatments: Other: non-interventional

Study type: Observational

Funder types: Industry

Identifiers

NCT00584519

A1281162

Details and patient eligibility

About

To analyse the progress of modifiable metabolic risk factors (Blood pressure, cigarette smoking, waist perimeter, BMI, glycemia and lipidic profile) in schizophrenic patients with overweight for 12 months.

To analyse the perceived health status and the level of functioning and disability of patients with schizophrenia and overweight and their progress at 3, 6 and 12 months.

To assess the progress of the symptoms of the disease at 6 and 12 months.

Full description

Consecutive patient sampling. Any investigational site four consecutive patients with diagnosis of Schizophrenia (DSM-IV TR) and Overweight (BMI more or equal to 25 Kg/m2)

Enrollment: 430 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with diagnosis of schizophrenia, schizophreniform or schizoaffective disorder (DSM-IV TR)
• Patients with BMI (body mass index) more or equal to 25 Kg/m2
• Patients or their legal representative have provided written informed consent

Exclusion criteria

• Patients are unable to complete or to understand health questionnaires in Spanish language
• Patients are currently enrolled on clinical trials or other investigational studies

Trial design

430 participants in 1 patient group

500 patients

Description:

Patients with diagnosis of schizophrenia, schizophreniform or schizoaffective disorder (DSM-IV TR) with BMI (body mass index) more or equal to 25 Kg/m2

Treatment:

Other: non-interventional